Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-5.70	36.12	38.30
Graham Fair Price	-24.38	229035.68	302867.89
PEG	415.99	-0.51	0.10
Price/Book	-7.94	1.00	1.08
Price/Cash Flow	-24.66	58.89	78.16
Prices/Earnings	63.56	21.89	13.38
Price/Sales	-6.42	3.94	4.21
Price/FCF	-24.66	58.89	78.16
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-8.58	0.11	0.12
Operating Margin	-4.23	0.08	0.08
ROA	-43.34	< 0.005	0.02
ROE	0.02	0.01	-43.71
ROIC	0.01	0.01	-11.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.12	-0.06	104.27
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.22	-0.06	-73.68
EPS QOQ	1.36	-0.43	-68.30
FCF QOQ	-0.73	0.22	-69.38
Revenue QOQ	0.05	-0.02	-69.33
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	111.56	98.11	-12.05
Days Sales Outstanding (DSO)	25.68	30.42	18.45
Inventory Turnover	0.81	0.92	13.70
Debt/Capitalization	0.09	0.09	11.29
Quick Ratio	1.45	1.73	19.37
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	449108.67	452689.74	0.80
Cash	99152.08	109700.47	10.64
Capex	-6832.58	-4483.62	34.38
Free Cash Flow	6217.95	7658.91	23.17
Revenue	115480.54	114512.75	-0.84
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.94	3.06	4.13
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.92	1.20	31.38
Naive Interpretation	Member

06 - Financial Health · Bad

Rating